Comment

The clinical utility of diagnostic markers extracted from liquid biopsies from cancer patients is hampered by knowledge gaps in biological understanding but can be aided by technological developments.

Soft integrated electronics packaged with miniaturized modules for wireless power and data transfer are opening up new opportunities for long-term health monitoring and therapy.

Shorter regulatory review times for high-risk cardiovascular devices correlate with the likelihood of reports of adverse events.

The increasing integration of wearable technologies with the human body raises neural and cognitive challenges and opportunities.